Durvalumab addition to chemo shows endometrial cancer benefit
Durvalumab addition to chemo shows endometrial cancer benefit
Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC
CheckMate-77T: Perioperative nivolumab benefit for NSCLC
Cost-benefit analysis of new cancer medicines: The difficult choices of governments
IMS 2023: Multiple myeloma roundup
OncoAlert Round Up for September 22-28, 2023
OncoAlert Round Up for September 1-7, 2023
The impact of SEABCS 2023
OncoAlert Round Up for August 25th - 31st, 2023
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
Latest in immunological technologies that can treat, control, and prevent cancer
AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours